Glossary
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
This glossary has been adapted from the NHMRCNational Health and Medical Research Council.
ADR | |
AIATSIS | Australian Institute of Aboriginal and Torres Strait Islander Studies |
Amendment requests | A change to an approved project |
ANZCTR | |
ARC | |
ARPANSA | |
ART | |
ASAM | Australian School of Advanced Medicine |
Benefits | Benefits of research may include, for example, gains in knowledge, insight and understanding, improved social welfare and individual wellbeing, and gains in skill or expertise for individual researchers, teams or institutions. |
Capitation payments | A fee or grant paid to a doctor, school, etc., the amount of which is determined by the number of patients, pupils or customers that are recruited to the research project. |
CBMS | Chemistry and Biomolecular Sciences |
CEO | Chief Executive Officer |
Children and/or young people | Persons who are under eighteen (18) years of age |
Clinical research | Clinical research involving humans seeks to find out whether an intervention – including treatments or diagnostic procedures – may improve a person's health. An intervention may involve testing a drug, a surgical or other therapeutic/preventative procedure, or a therapeutic/preventative/diagnostic device, practice or service |
Clinical trial | Research involving an unapproved or approved therapeutic goods, intervention or treatment |
COI | Conflict of Interest |
Conflict of Interest | Where a person's individual interests or responsibilities have the potential to influence the carrying out of his or her institutional role or professional obligations in research; or where an institution's interests or responsibilities have the potential to influence the carrying out of its research obligations |
Coordinating (Principalprincipal) investigator | The person who – in a multi-site research project, where Macquarie University is providing ethical review for more than one institution/site – is the primary point of contact between the groups of collaborating investigators/researchers and the HREC |
CPI | Coordinating (Principal) Investigator |
CTN | Clinical Trial Notification |
CTP | Clinical Trial Protocol |
CTX | Clinical Trial Exemption |
Discomfort | Discomforts (less serious than harm) can involve body and/or mind and include: |
Discontinue | The process by which a principal or coordinating investigator notifies the Human Research Ethics Committee responsible for providing ethics approval that a project will not be completed. |
DNA | Deoxyribonucleic Acid |
DSMB | Data and Safety Monitoring Board |
Duality of interest | Where two or more interests co-exist. These interests may or may not conflict, depending on the specific circumstances. |
External review | A Macquarie University process, applicable only to internal applicants for externally-approved projects where all of the research will be conducted offsite (ie does not take place at Macquarie University or at Macquarie University Hospital). Investigators must also be listed on the external application (either by an amendment or as a named Principal Investigator). |
Genetic research | The evaluation of somatic genetics/epigenetics of cells in which the primary purpose is not to identify germline disease-predisposing mutations. |
Genetic testing | The analysis of genetic material in which the primary purpose is to identify high or low penetrance germline disease-predisposing mutations. |
Harm | No list of potential harms in research will be exhaustive; however, the following classifications may assist: |
HDRO | |
HoD or HOD | Head of Department |
HREC | |
HTML | Hypertext Markup Language |
HUM | Human Sciences and Humanities |
Human Research Ethics Committee | An institutional body that has been established in accordance with Chapter 5.1 of the National Statement and conducts the ethical review of research. |
Human Tissue tissue samples | Includes blood, tissue, sputum, urine or autopsy with or without tissue retention. |
Inconvenience | Examples of inconvenience (less serious than harm and discomfort) may include: |
Institution | The entity responsible for the conduct of research as described in the National Statement and the Code. Alternatively, the entity that has established a HREC as per Chapter 5.1 of the National Statement. |
IPP | Information Privacy Principle |
IRIS | Integrated Research Information System |
LNR | Low and/or negligible risk (research) |
Low risk research | Where the only foreseeable risk is one of discomfort to the research participant (see National Statement Chapter 2.1). |
MDS | Medical Sciences |
MGSM | |
MQ | |
MUH | |
Multi-centre research | A research project undertaken by a group of institutions (or individuals) at one or more sites (as defined by the NHMRC). |
Multi | A Macquarie University process, where Macquarie University assumes oversight of one or more external institutions/sites. For external applicants, this would apply where Macquarie University oversight involves two or more external institutions/sites. This type of application needs to report on all research personnel and project details that apply to the sites for which the Macquarie University will be providing ethical review. |
HREA | The Human Research Ethics Application Form |
Negligible research | Where there is no foreseeable risk of harm or discomfort, and any foreseeable risk is no more than one of inconvenience to the research participant (see National Statement Chapter 2.1). |
NHMRC | National Health and Medical Research Council |
NPP | National Privacy Principle |
NS or National Statement | National Statement on Ethical Conduct in Human Research 2007 |
NSW | New South Wales |
OGTR | Office of the Gene Technology Regulator |
PACE | Participation and Community Engagement |
Portable Document Format (ie Adobe Acrobat/Reader document) | |
PI | Principal Investigator |
PICF | Participant Information and Consent Form |
Principal investigator | The person who is the principal point of contact with the HREC for all the research personnel listed in the research proposal. Principal Investigator (or PI) should be used in the following circumstances: |
Prior review | A Macquarie University process, for instance where researchers (namely those in medical sciences) wish to obtain ethical review from Macquarie University for an additional (single) site – ie one that was not covered by a previous application that received approval from one of the following types of external HRECs: |
Protocol | A document that provides the background, rationale and objectives of the proposed research and describes its design, methodology, organisation and the conditions under which it is to be performed and managed. |
Research | Original investigation undertaken to gain knowledge, understanding and insight (see National Statement and the Code). |
RIHE | Research Involving Human Embryos |
Risk | A risk is a potential for harm, discomfort or inconvenience and involves: |
RME | Research Master Enterprises |
RNA | Ribonucleic Acid |
RPS | Radiation Protection Series |
SAE | Serious Adverse Event |
Scientific review | A review of proposed research to consider the level of scientific validity of research methodology before the proposal is considered by a HREC. |
SERAP | State Education Research Applications Process |
SIBT | Sydney Institute of Business and Technology |
Single-site research | A research project undertaken at a single location |
Site | The location(s) at which the research is being conducted – namely in reference to universities, schools, hospitals and other health practices/clinics |
SUSAR | Serious Unexpected Suspected Adverse Reaction |
The Code | Australian Code for the Responsible Conduct of Research (2007) |
TGA | Therapeutic Goods Administration |
URL | Uniform Resource Locator (ie a web address) |
WHS | Work Health and Safety |